[Therapeutic correction with retabolil of functional plastic dissociation during strophanthin use on acute myocardial infarct patients].
D000328:Adult; D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use*; D001798:Blood Proteins / Q000378:metabolism; D004573:Electrolytes / Q000097:blood; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D009277:Nandrolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077603:Nandrolone Decanoate; D012709:Serum Albumin / Q000378:metabolism; D013328:Strophanthins / Q000009:adverse effects*; D013997:Time Factors
D045930:Anabolic Agents; D001798:Blood Proteins; D004573:Electrolytes; D012709:Serum Albumin; D013328:Strophanthins; D009277:Nandrolone; D000077603:Nandrolone Decanoate
Terapevticheskaia korrektsiia retabolila fenomena funktsional'no-plasticheskoĭ dissotsiatsii pri primenenii strofantina u bol'nykh ostrym infarktom miokarda.